Versant Venture Management, LLC Passage Bio, Inc. Transaction History
Versant Venture Management, LLC
- $45 Million
- Q2 2024
A detailed history of Versant Venture Management, LLC transactions in Passage Bio, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 4,026,417 shares of PASG stock, worth $2.5 Million. This represents 7.06% of its overall portfolio holdings.
Number of Shares
4,026,417
Previous 4,959,769
18.82%
Holding current value
$2.5 Million
Previous $6.7 Million
52.5%
% of portfolio
7.06%
Previous 9.33%
Shares
2 transactions
Others Institutions Holding PASG
# of Institutions
44Shares Held
32.7MCall Options Held
8.3KPut Options Held
400-
Orbimed Advisors LLC San Diego, CA10.1MShares$6.28 Million0.19% of portfolio
-
Vestal Point Capital, LP New York, NY6.05MShares$3.75 Million0.36% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$1.55 Million2.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$1.28 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.5MShares$930,0000.14% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $33.8M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...